- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| Fr | Bigblu Broadband - H219 trading in line, confident in FY20 | 54 | Bigblu's trading statement confirmed an H2 performance in line with expectations. Actions to cleanse the customer base should yield operational benefits over time and the above consensus year-end net... ► Artikel lesen | ||
| Fr | De La Rue - Securing the future | 122 | De La Rue remains challenged. New management has to navigate a difficult Currency market and consequent concern over its finances. The swift response in terms of a turnaround programme is a positive... ► Artikel lesen | ||
| Fr | Tonkens Agrar - Drought affects profits | 135 | Tonkens continued with its strategy of increasing volumes of higher-margin processed vegetables in FY18/19, supporting a 17% y-o-y increase in group revenue. However, as flagged by management in March... ► Artikel lesen | ||
| Fr | Diversified Gas and Oil - Roadmap to Main Market | 311 | Diversified Gas and Oil (DGO) has announced the successful completion of its securitised financing arrangement with a 5% coupon and 10-year maturity. The company issued $200m in notes secured by c 22%... ► Artikel lesen | ||
| Do | Solid State - Record trading in H120 | 63 | Solid State delivered an 11% pro forma increase in group revenues and a 60% jump in adjusted profit before tax during H120. While some of this increase was attributable to factors such as favourable... ► Artikel lesen | ||
| Do | SymBio Pharmaceuticals - Treakisym has positive DLBCL results | 64 | On 5 November 2019, SymBio announced it obtained positive results in its pivotal Phase III clinical trial of Treakisym (bendamustine) in patients with relapsed and refractory diffuse large B-cell lymphoma... ► Artikel lesen | ||
| Do | Britvic - Evolution to drive continued growth | 138 | In FY19 Britvic delivered a strong performance showing good momentum in its core business. The GB business had both Britvic and PepsiCo brands showing revenue growth, Brazil continues to grow and problems... ► Artikel lesen | ||
| Mi | Ryvu Therapeutics - First ever clinical data from lead assets in 2020 | 87 | Ryvu Therapeutics (formerly Selvita) is now trading as a standalone biotech after its drug discovery services business was spun out in October 2019. According to the recent Q319 report, R&D progress... ► Artikel lesen | ||
| Mi | Laboratorios Farmacéuticos ROVI - Multiple growth drivers lie ahead | 112 | Following Laboratorios Farmacéuticos ROVI's (ROVI's) recent investor day, we have reviewed our near-term forecasts. Specifically, we upgrade our Becat (enoxaparin biosimilar) peak sales forecasts and... ► Artikel lesen | ||
| Mi | Coro Energy - Italian asset disposal and Bulu acquisition update | 113 | Coro Energy has provided an update on both the disposal of its non-core Italian assets and its Bulu PSC acquisition offshore East Java. Coro has entered into a conditional sale and purchase agreement... ► Artikel lesen | ||
| Di | Redhill Biopharma - 2020 set to be a commercially transformative year | 183 | On 22 November 2019, RedHill held an investor and analyst day in New York with the focus on the two new products about to be launched in the US. Talicia and Aemcolo are to be launched imminently (Q419... ► Artikel lesen | ||
| Di | Amur Minerals - Russian TEO status | 93 | On 4 November, Amur announced it had raised £1.2m (gross) via the issue of 70.6m shares at a price of 1.7p per share from an asset manager 'specialising in natural resources'. This share issue is of... ► Artikel lesen | ||
| Di | Targovax - Data from both lead trials due H120 | 114 | Both lead clinical trials with ONCOS-102 are expected to deliver results over the next few months, which will make H120 one the most eventful periods in Targovax's history. Data from Phase I/II trial... ► Artikel lesen | ||
| Di | OpGen - Shareholder votes on Curetis merger coming | 1.452 | In September, OpGen announced a merger with Curetis, a Germany-based molecular diagnostics company with a similar focus on infectious disease. Curetis has two main business lines, the Unyvero A50 high-plex... ► Artikel lesen | ||
| Di | Gemfields Group - Strong November emerald auction | 118 | Gemfields' November high-quality emerald auction sale of US$27.2m reflects strong demand for Kagem's emeralds and, more broadly, points to continued strength in the coloured gemstone market. Completion... ► Artikel lesen | ||
| Mo | Hurricane Energy - Warwick West discovery | 131 | This morning Hurricane Energy announced the flow test results from its Warwick West well, which is the third and last well from the 2019 drilling campaign in the Greater Warwick Area (GWA). The well... ► Artikel lesen | ||
| Mo | Kazia Therapeutics - GDC-0084 - encouraging initial efficacy | 81 | Kazia Therapeutics has presented very encouraging initial efficacy data from the dose-ranging stage of its current Phase II trial. The data are sufficient to give Kazia confidence that it can run a... ► Artikel lesen | ||
| Mo | Keywords Studios - Confidence in its sustainable model | 164 | At the capital markets day (CMD) on 14 November, management offered a comprehensive review of Keywords' business and its drivers. This was the first event with Jon Hauck formally in place as CFO, who... ► Artikel lesen | ||
| Mo | Palace Capital - Investing for growth | 92 | During H120, Palace stepped up its refurbishment and development activity aimed at improving the quality of the portfolio and enhancing its income and valuation potential over the longer term. The flagship... ► Artikel lesen | ||
| Mo | BioPorto Diagnostics - FDA - more data needed for paediatric AKI | 111 | Following an interaction with the FDA, BioPorto announced on 18 November 2019 that it will need to gather more data to complete the 510(k) application for the paediatric NGAL Test. The company expects... ► Artikel lesen | ||
| Mo | Egdon Resources - 2020 focus on conventional assets | 133 | Egdon Resources' recently announced results showed that FY19 production increased by 117% to 182boepd, largely driven by the Ceres gas field. Revenue increased to £2.2m from £1.2m in FY18 and the company... ► Artikel lesen | ||
| 29.11. | Princess Private Equity Holding - Steady realisations support dividend payout | 156 | Following high investment activity in 2018, which allowed Princess Private Equity (PEY) to become fully invested, its balance of new investments vs realisations has been broadly neutral so far in 2019.... ► Artikel lesen | ||
| 29.11. | Quadrise Fuels International - Initial pilot trial in Morocco | 180 | Quadrise has entered into an agreement with an international chemicals and mining group headquartered in Morocco. During calendar Q120 the two parties will work together on a project to carry out a... ► Artikel lesen | ||
| 28.11. | Hutchison China MediTech - Elunate receives China NRDL inclusion | 220 | Hutchison China MediTech (HCM) has announced that Elunate (fruquintinib capsules) have been included in China's National Reimbursement Drug List (NRDL) by the National Healthcare Security Administration... ► Artikel lesen | ||
| 28.11. | Record - Enhancing products and service | 128 | Record has maintained its commitment to improving service levels and introducing new products to meet client needs. In H120 this included a new strategy within the currency for return area and it is... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
